PlexusDx's tirzepatide injection is $289/mo month-to-month, or from $249/mo on the 6-month plan (flat pricing across all dose levels), while oral tirzepatide is $349/mo month-to-month (or $279/mo on the 6-month plan)both accessible without insurance or membership fees
In 2005, the first GLP-1 receptor agonist, exenatide (marketed as Byetta), was approved by the US Food and Drug Administration and subsequently received European authorisation through the European Medicines Agency (EMA)
There is no conclusive evidence linking GLP-1 medications to cancer in humans
Not everyone responds to semaglutide (Wegovy) in the same way
While certain competitors may engage in price or generic competition, the sustainability of such leadership will only be achieved by players who have differentiated oral delivery systems, solid trial data, robust real-world evidence, wide distribution reach, and proper positioning in the obese care pathway